Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients
The Prostate2016Vol. 76(14), pp. 1239–1256
Citations Over TimeTop 12% of 2016 papers
Ahva Shahabi, Juan Pablo Lewinger, Jie Ren, Craig April, Andy Sherrod, Joseph G. Hacia, Siamak Daneshmand, Inderbir S. Gill, Jacek Pinski, Jian‐Bing Fan, Mariana C. Stern
Abstract
We report a novel gene-expression based classifier identified using agnostic approaches from whole genome expression profiles that can improve upon the accuracy of clinical indicators to stratify early stage localized patients at risk of clinical recurrence after RP. Prostate 76:1239-1256, 2016. © 2016 Wiley Periodicals, Inc.
Related Papers
- → Biochemical recurrence after radical prostatectomy: what does it mean?(2018)153 cited
- → Length of Positive Surgical Margin After Radical Prostatectomy as a Predictor of Biochemical Recurrence(2009)108 cited
- → The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy(2014)42 cited
- → Biochemical recurrence after radical prostatectomy: is the disease or the surgeon to blame?(2011)3 cited
- → <p>Statins Prevent Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Single-center Retrospective Study with a Median Follow-up of 51.20 Months</p>(2020)3 cited